This federal contract award, valued at $1,658.88, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The contract is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. Dakota Drug, Inc. has a proven track record as a key strategic supplier for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,266.06 fixed-price delivery order is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to supply a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a firm fixed price of $1,403.50 and a completion date of January 27, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) identified as SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a comprehensive...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,640.80, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,106.58, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical's ECAT...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJMRZ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Firm Fixed Price Delivery Order, is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a ceiling value of $4,112.43 and a completion date of November 14, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
This is a federal contract award (SPE2DX15D8003|SPE2DX24F7C1V) from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The $13,204.40 firm fixed-price delivery order contract has a period of performance through December 29, 2023. Dakota Drug, Inc. is a key supplier to DLA, holding a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $2,892.14, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award is a Delivery Order under the larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, worth $999,999,999.00, which allows Dakota Drug to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The specific contract award,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,023.85, is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This contract does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA, providing a wide range of pharmaceutical products, medical supplies, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract has a ceiling value of $2,554.39 and is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation. This award is associated with a larger Indefinite Delivery Contract (IDC)...